Torthaí cuardaigh - Jonathan Nyong
- 1 - 6 toradh as 6 á dtaispeáint
-
1
-
2
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction de réir R. Thomas Lumbers, Nicole Martin, Karthick Manoharan, Jonathan Nyong, James Thomas, Juan P. Casas, Ceri Davies
Foilsithe / Cruthaithe 2017Artigo -
3
Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation de réir Jonathan Nyong, Guy Amit, Alma J Adler, Onikepe Owolabi, Pablo Perel, David Prieto‐Merino, Pier D. Lambiase, Juan P. Casas, Carlos A. Morillo
Foilsithe / Cruthaithe 2016Revisão -
4
Statins for aortic valve stenosis de réir Luciana Thiago, Selma Rumiko Tsuji, Jonathan Nyong, Maria Eduarda dos Santos Puga, Aécio Flávio Teixeira de Góis, Cristiane R Macedo, Orsine Valente, Álvaro Nagib Atallah
Foilsithe / Cruthaithe 2016Revisão -
5
Statins for aortic valve stenosis de réir Luciana Thiago, Selma Rumiko Tsuji, Jonathan Nyong, Maria Eduarda dos Santos Puga, Aécio Flávio Teixeira de Góis, Cristiane R Macedo, Orsine Valente, Álvaro Nagib Atallah
Foilsithe / Cruthaithe 2016Carta -
6
Development of mWellcare: an mHealth intervention for integrated management of hypertension and diabetes in low-resource settings de réir Devraj Jindal, Priti Gupta, Dilip Jha, Vamadevan S. Ajay, Shifalika Goenka, Pramod Jacob, Kriti Mehrotra, Pablo Perel, Jonathan Nyong, Ambuj Roy, Nikhil Tandon, Dorairaj Prabhakaran, Vikram Patel
Foilsithe / Cruthaithe 2018Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Medicine
Cardiology
Internal medicine
Randomized controlled trial
Adverse effect
Alternative medicine
Aortic valve replacement
Aortic valve stenosis
Endocrinology
Meta-analysis
Pathology
Placebo
Stenosis
valvular heart disease
Ablation
Aldosterone
Angiotensin II receptor type 1
Atrial fibrillation
Blood pressure
Business
Catheter ablation
Clinical trial
Computer network
Computer science
Confidence interval
Diabetes management
Diabetes mellitus
Ejection fraction
Gerontology
Heart disease